Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 103Neoplasms, Plasma Cell 11Immunoglobulin Light-chain Amyloidosis 11Recurrence 10Leukemia, Myeloid, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasm, Residual 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Paraproteinemias 3Neoplasms 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Smoldering Multiple Myeloma 2Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Plasma Cell 2Hodgkin Disease 2Hematologic Diseases 2Corneal Diseases 2Blood Protein Disorders 2Amyloidosis 2Acute Kidney Injury 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Renal Insufficiency 1Proteostasis Deficiencies 1Primary Myelofibrosis 1Plasmacytoma 1

Interventions

Cytarabine 39Busulfan 15Idarubicin 14Cyclophosphamide 13Mitoxantrone 12Filgrastim 12Etoposide 12fludarabine phosphate 11Peripheral Blood Stem Cell Transplantation 11Daunorubicin 9Methotrexate 8Cyclosporine 8Tacrolimus 7Whole-Body Irradiation 5Mycophenolic Acid 5Clofarabine 5Cladribine 5Biopsy 5Azacitidine 5Arsenic Trioxide 5Antilymphocyte Serum 5Radiotherapy 4Gemtuzumab 4Flow Cytometry 4Decitabine 4Cyclosporins 4venetoclax 3pegylated granulocyte colony-stimulating factor 3Topotecan 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Monocytic, Acute × daratumumab × Clear all
NCT04714372 2024-10-24

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
9 enrolled 16 charts
Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡